{"id":"single-drug-references","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T04:27:07.827Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123021,"model":"claude-sonnet-4-5-20250929"},"description":"Single drug references is an investigational pharmaceutical compound currently in Phase 1 clinical development by Pfizer. Limited public information is available regarding its molecular target, mechanism of action, or intended therapeutic applications at this early stage of development.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT07495007","phase":"PHASE1","title":"An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection","status":"COMPLETED","sponsor":"Zi Diligence Biocenter","startDate":"2025-11-10","conditions":"Bioequivalance, Post-menopause","enrollment":26},{"nctId":"NCT06536296","phase":"NA","title":"The Impact of Music Medicine on Preterm Brain Development and Behavior","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-05-19","conditions":"Infant Development, Language Development, Prematurity","enrollment":243},{"nctId":"NCT06983665","phase":"NA","title":"Human Bioequivalence Study of Liposomal Amphotericin B for Injection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2025-05-25","conditions":"Invasive Fungal Infections, Neutropenic Fever, Visceral Leishmaniasis","enrollment":42},{"nctId":"NCT07470866","phase":"PHASE1","title":"A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions","status":"NOT_YET_RECRUITING","sponsor":"Pfizer","startDate":"2026-03-27","conditions":"Healthy","enrollment":24},{"nctId":"NCT07476157","phase":"PHASE1","title":"A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects","status":"NOT_YET_RECRUITING","sponsor":"Addpharma Inc.","startDate":"2026-04","conditions":"Chronic Heart Failure","enrollment":70},{"nctId":"NCT07478133","phase":"NA","title":"Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans","status":"COMPLETED","sponsor":"Shandong New Time Pharmaceutical Co., LTD","startDate":"2023-05-24","conditions":"Pruritus","enrollment":72},{"nctId":"NCT07477119","phase":"PHASE4","title":"Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment","status":"NOT_YET_RECRUITING","sponsor":"Marco Schiuma","startDate":"2026-03","conditions":"Linezolid, Tuberculosis Multi Drug Resistant Active, Therapeutic Drug Monitoring (TDM)","enrollment":150},{"nctId":"NCT07345130","phase":"PHASE1","title":"A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions","status":"COMPLETED","sponsor":"HALEON","startDate":"2025-12-17","conditions":"Bioequivalence, Bioavailability","enrollment":50},{"nctId":"NCT07463664","phase":"NA","title":"Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2025-04-28","conditions":"Chronic Total Occlusions of Coronary Arteries, Chronic Total Occlusion (CTO), Coronary Artery Disease (CAD)","enrollment":200},{"nctId":"NCT03660826","phase":"PHASE2","title":"Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-09-27","conditions":"Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma","enrollment":288},{"nctId":"NCT06021600","phase":"PHASE1","title":"A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-10-09","conditions":"Leukemia, Myelodysplastic Syndromes, Acute Myeloid Leukemia","enrollment":40},{"nctId":"NCT06765590","phase":"NA","title":"Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer","status":"RECRUITING","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2025-03-12","conditions":"Breast Cancer","enrollment":24},{"nctId":"NCT07154433","phase":"NA","title":"A Study on Reducing Opioid Use After Minimally Invasive Ankle Surgery","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Ankle (Ligaments); Instability (Old Injury), Ankle Sprain, Talus Osteochondral Defect","enrollment":110},{"nctId":"NCT04852601","phase":"NA","title":"ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2022-08-25","conditions":"Cognitive Dysfunction, Dementia","enrollment":41500},{"nctId":"NCT02502266","phase":"PHASE2, PHASE3","title":"Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-05-03","conditions":"Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma","enrollment":582},{"nctId":"NCT07444385","phase":"PHASE1","title":"A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects","status":"RECRUITING","sponsor":"Addpharma Inc.","startDate":"2026-02-26","conditions":"Benign Prostatic Hyperplasia","enrollment":44},{"nctId":"NCT07443631","phase":"NA","title":"Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants","status":"RECRUITING","sponsor":"Philip Morris Products S.A.","startDate":"2026-02-19","conditions":"Smoking","enrollment":108},{"nctId":"NCT07049055","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer","status":"RECRUITING","sponsor":"Engeneic Pty Limited","startDate":"2026-01-12","conditions":"Pancreatic Cancer, Metastatic, PDAC - Pancreatic Ductal Adenocarcinoma","enrollment":144},{"nctId":"NCT07268625","phase":"PHASE1","title":"Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-12-09","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT07261371","phase":"PHASE1","title":"A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-11-24","conditions":"Healthy Volunteer","enrollment":64},{"nctId":"NCT07097259","phase":"PHASE1","title":"A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants","status":"COMPLETED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2025-07-21","conditions":"Hypogonadism","enrollment":55},{"nctId":"NCT07212114","phase":"PHASE3","title":"Efficacy of EXPAREL vs. Bupivacaine","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-11-17","conditions":"Total Ankle Arthroplasty, Postsurgical Analgesia","enrollment":104},{"nctId":"NCT06929052","phase":"PHASE1","title":"A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects.","status":"COMPLETED","sponsor":"Kashiv BioSciences, LLC","startDate":"2025-01-29","conditions":"Healthy Adult Subjects","enrollment":150},{"nctId":"NCT07420881","phase":"NA","title":"Start4All - Start Taking Action for TB Diagnosis (DARE-TB)","status":"NOT_YET_RECRUITING","sponsor":"Liverpool School of Tropical Medicine","startDate":"2026-03-01","conditions":"TB - Tuberculosis","enrollment":60000},{"nctId":"NCT07331194","phase":"PHASE1","title":"Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in Humans","status":"COMPLETED","sponsor":"Hutchmed","startDate":"2025-10-28","conditions":"Healthy","enrollment":54},{"nctId":"NCT07385235","phase":"PHASE1","title":"Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'","status":"RECRUITING","sponsor":"Addpharma Inc.","startDate":"2026-01-27","conditions":"Gastric Ulcer","enrollment":46},{"nctId":"NCT07404735","phase":"PHASE1","title":"A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846","status":"NOT_YET_RECRUITING","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2026-02-23","conditions":"Benign Prostate Hypertrophy(BPH)","enrollment":32},{"nctId":"NCT07399470","phase":"PHASE1","title":"A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.","status":"ACTIVE_NOT_RECRUITING","sponsor":"LG Chem","startDate":"2026-01-09","conditions":"Healthy Volunteers, Fasting Conditions","enrollment":58},{"nctId":"NCT04127786","phase":"PHASE3","title":"Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2019-10-21","conditions":"Rabies, Healthy Volunteers","enrollment":1708},{"nctId":"NCT07396506","phase":"NA","title":"Bioequivalence Study of Dronedarone Hydrochloride Tablets in Healthy Subjects Under Fasting Conditions","status":"COMPLETED","sponsor":"Shandong New Time Pharmaceutical Co., LTD","startDate":"2023-06-05","conditions":"Atrial Fibrillation (AF)","enrollment":51},{"nctId":"NCT07396519","phase":"NA","title":"Bioequivalence Study of Dronedarone Hydrochloride Tablets","status":"COMPLETED","sponsor":"Shandong New Time Pharmaceutical Co., LTD","startDate":"2022-11-14","conditions":"Atrial Fibrillation (AF)","enrollment":48},{"nctId":"NCT07397832","phase":"PHASE2","title":"CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL","status":"RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2026-01-30","conditions":"Diffuse Large B-Cell Lymphoma (DLBCL)","enrollment":58},{"nctId":"NCT07391904","phase":"NA","title":"Patient-centered Precision Medicine Lab Result Communication for Older Adults","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-02-02","conditions":"Chronic Kidney Disease (CKD), Health Communication, Patient Comprehension","enrollment":255},{"nctId":"NCT05796362","phase":"PHASE1","title":"A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2024-08-08","conditions":"Infectious Disease, Drug Effect, Clinical Infection","enrollment":18},{"nctId":"NCT07384104","phase":"PHASE1","title":"Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects","status":"ENROLLING_BY_INVITATION","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2025-10-19","conditions":"Osteoporosis","enrollment":118},{"nctId":"NCT07382375","phase":"NA","title":"AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Medical University","startDate":"2027-12-31","conditions":"Aortic Aneurysm and Dissection","enrollment":300},{"nctId":"NCT07235189","phase":"PHASE1","title":"A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-10-28","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT07300436","phase":"PHASE1","title":"A Study of TJ101 Injection Before and After CMC Change Following Subcutaneous Injection in Healthy Adult Male Subjects in China","status":"RECRUITING","sponsor":"TJ Biopharma Co., Ltd.","startDate":"2026-01-04","conditions":"Healthy Adult Males in China","enrollment":96},{"nctId":"NCT07372118","phase":"PHASE1","title":"Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2025-09-27","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":32},{"nctId":"NCT07374406","phase":"PHASE1","title":"To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers","status":"RECRUITING","sponsor":"JW Pharmaceutical","startDate":"2026-01-14","conditions":"Healthy","enrollment":34},{"nctId":"NCT06444308","phase":"NA","title":"Community Health Worker-led Hypertension Management","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-09-09","conditions":"Hypertension","enrollment":460},{"nctId":"NCT07370233","phase":"PHASE2","title":"Triple Therapy Strategy for Managing Persistent Pain After Spinal Microdiscectomy","status":"COMPLETED","sponsor":"Benha University","startDate":"2023-02-20","conditions":"Spinal Disk Injury","enrollment":63},{"nctId":"NCT07367711","phase":"","title":"The Influence of Chemotherapy on Position Sense","status":"NOT_YET_RECRUITING","sponsor":"KU Leuven","startDate":"2026-02","conditions":"CIPN - Chemotherapy-Induced Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer","enrollment":145},{"nctId":"NCT07362498","phase":"","title":"Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya","status":"COMPLETED","sponsor":"Strathmore University","startDate":"2020-06-01","conditions":"Malaria Falciparum","enrollment":316},{"nctId":"NCT07364669","phase":"PHASE1","title":"Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy Subjects","status":"COMPLETED","sponsor":"Laboratorios Pisa S.A. de C.V.","startDate":"2024-10-24","conditions":"Healthy Subjects","enrollment":40},{"nctId":"NCT07354646","phase":"","title":"The Application of T1 Mapping in Real-World","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2020-03-01","conditions":"Myocardial Infarction (MI), Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM)","enrollment":2000},{"nctId":"NCT03972488","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Advanced Accelerator Applications","startDate":"2020-01-08","conditions":"Gastro-enteropancreatic Neuroendocrine Tumor","enrollment":226},{"nctId":"NCT06110923","phase":"PHASE1","title":"A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-11-13","conditions":"Benign Prostate Hypertrophy(BPH)","enrollment":31},{"nctId":"NCT07333742","phase":"PHASE1","title":"A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal","status":"COMPLETED","sponsor":"LG Chem","startDate":"2025-09-29","conditions":"Fed Conditions, Healthy Volunteer","enrollment":50},{"nctId":"NCT07319039","phase":"","title":"Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study","status":"RECRUITING","sponsor":"University Hospital, Geneva","startDate":"2025-08-26","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Heart Failure, Cancer","enrollment":16},{"nctId":"NCT06729073","phase":"PHASE1","title":"Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.","status":"COMPLETED","sponsor":"Amzell","startDate":"2024-11-29","conditions":"Healthy Volunteer","enrollment":34},{"nctId":"NCT07220551","phase":"PHASE1","title":"A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2025-10-23","conditions":"Healthy Volunteers","enrollment":14},{"nctId":"NCT07133399","phase":"PHASE1","title":"A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2025-09-08","conditions":"Healthy","enrollment":32},{"nctId":"NCT05387512","phase":"","title":"A Real World Study of β2-Adrenergic Blocker Plus PD-1 Inhibitor in Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-01-12","conditions":"Lung Cancer","enrollment":59},{"nctId":"NCT07316608","phase":"PHASE1","title":"A Phase I, Open-label, Crossover Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-03-16","conditions":"Healthy Participants","enrollment":44},{"nctId":"NCT07286981","phase":"NA","title":"Glycemic Index of Date Cultivars and Date-based Products","status":"COMPLETED","sponsor":"King Saud University","startDate":"2024-08-16","conditions":"Glycaemic Response Measurements","enrollment":40},{"nctId":"NCT06397144","phase":"PHASE1","title":"A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2025-08-15","conditions":"Biological Availability, Healthy Participants","enrollment":""},{"nctId":"NCT06831344","phase":"PHASE1","title":"A Study to Evaluate Two Vonoprazan Orally Disintegrating Tablet Formulations Administered Without Water or Mixed With Water and Administered Via a Syringe Relative to the Vonoprazan Tablet in Healthy Participants","status":"COMPLETED","sponsor":"Phathom Pharmaceuticals, Inc.","startDate":"2025-02-14","conditions":"Healthy Volunteers","enrollment":25},{"nctId":"NCT07201545","phase":"PHASE1","title":"Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-10-07","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT07287852","phase":"PHASE2","title":"A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI","status":"ENROLLING_BY_INVITATION","sponsor":"Hadassah Medical Organization","startDate":"2024-08-20","conditions":"Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)","enrollment":50},{"nctId":"NCT07182383","phase":"PHASE1","title":"Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-09-29","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT06768619","phase":"NA","title":"Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-03-20","conditions":"Thrombocytopenia","enrollment":36},{"nctId":"NCT06689527","phase":"PHASE1","title":"Evaluation of Vamorolone CYP3A4 Induction on Midazolam (a Sensitive CYP 3A4 Substrate) Pharmacokinetics","status":"COMPLETED","sponsor":"Santhera Pharmaceuticals","startDate":"2024-08-13","conditions":"Drug Interaction","enrollment":18},{"nctId":"NCT04690933","phase":"","title":"AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2020-09-24","conditions":"Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Antivirals","enrollment":400},{"nctId":"NCT07268729","phase":"","title":"Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders","status":"NOT_YET_RECRUITING","sponsor":"University of Toronto","startDate":"2025-12-10","conditions":"Anxiety, Panic Disorder, Mood Disorders","enrollment":500},{"nctId":"NCT07266766","phase":"PHASE1","title":"Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2025-08-05","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":40},{"nctId":"NCT07266779","phase":"PHASE1","title":"Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets in Healthy, Adult, Human Subjects Under Fed Condition.","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2025-08-22","conditions":"Type 2 Diabetes","enrollment":36},{"nctId":"NCT06070610","phase":"PHASE1","title":"A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2023-11-08","conditions":"Healthy","enrollment":14},{"nctId":"NCT06494761","phase":"PHASE1","title":"A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-07-30","conditions":"Healthy","enrollment":16},{"nctId":"NCT06393127","phase":"PHASE1","title":"A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-06-04","conditions":"Healthy","enrollment":64},{"nctId":"NCT07254325","phase":"PHASE1","title":"Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Taizhou Mabtech Pharmaceutical Co.,Ltd","startDate":"2025-12-15","conditions":"Psoriasis","enrollment":114},{"nctId":"NCT07130097","phase":"PHASE1","title":"A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants","status":"COMPLETED","sponsor":"Pfizer","startDate":"2025-08-14","conditions":"Healthy Participant","enrollment":35},{"nctId":"NCT06977490","phase":"NA","title":"Human Bioequivalence Study of Amphotericin B Liposome for Injection","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2025-05-13","conditions":"Invasive Fungal Infections, Neutropenic Fever, Visceral Leishmaniasis","enrollment":42},{"nctId":"NCT06018545","phase":"","title":"AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation","status":"COMPLETED","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2023-06-01","conditions":"Intracranial Hemorrhages, Acute Ischemic Stroke, Hydrocephalus","enrollment":33},{"nctId":"NCT06749236","phase":"PHASE1","title":"A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension","status":"COMPLETED","sponsor":"Vigonvita Life Sciences","startDate":"2025-08-11","conditions":"Healthy Participants","enrollment":18},{"nctId":"NCT07222878","phase":"PHASE1","title":"Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042","status":"RECRUITING","sponsor":"NeuroPro Therapeutics, Inc.","startDate":"2025-09-29","conditions":"Epilepsy, Alzheimer Disease, Epilepsy Intractable","enrollment":8},{"nctId":"NCT06916143","phase":"PHASE1","title":"Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-04-08","conditions":"Healthy Participants","enrollment":48},{"nctId":"NCT03520686","phase":"PHASE3","title":"Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2018-05-18","conditions":"Non Small Cell Lung Cancer","enrollment":1538},{"nctId":"NCT07202052","phase":"PHASE2, PHASE3","title":"Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)","status":"RECRUITING","sponsor":"Monash University","startDate":"2025-05-06","conditions":"Myeloma, Non-Hodgkin's Lymphoma, Leukemia","enrollment":900},{"nctId":"NCT05879991","phase":"PHASE1","title":"A Study in Healthy Men to Test How Zongertinib (BI 1810631) is Taken up and Processed by the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2023-08-10","conditions":"Healthy","enrollment":15},{"nctId":"NCT06902818","phase":"PHASE1","title":"The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2025-03-21","conditions":"Gastric Ulcer","enrollment":46},{"nctId":"NCT07156916","phase":"PHASE1","title":"A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions","status":"RECRUITING","sponsor":"Berlin-Chemie AG Menarini Group","startDate":"2025-09-08","conditions":"Healthy Volunteer Male Subjects","enrollment":46},{"nctId":"NCT07103278","phase":"PHASE1","title":"A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Addpharma Inc.","startDate":"2025-12","conditions":"Benign Prostatic Hyperplasia","enrollment":44},{"nctId":"NCT06858865","phase":"PHASE1","title":"A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2025-07-12","conditions":"Primary Hypercholesterolaemia","enrollment":60},{"nctId":"NCT06265272","phase":"","title":"Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-10","conditions":"Liver Cirrhosis, Hepatic Cell Carcinoma, Portal Hypertension","enrollment":45},{"nctId":"NCT06326697","phase":"PHASE1","title":"Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)","status":"COMPLETED","sponsor":"Hikma Pharmaceuticals LLC","startDate":"2024-05-02","conditions":"Acute Myeloid Leukaemia","enrollment":32},{"nctId":"NCT07194057","phase":"","title":"\"A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the European Reference Network\"","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2025-09-30","conditions":"Transplant Complication, Kidney Transplant, Liver Transplant","enrollment":200},{"nctId":"NCT03903016","phase":"PHASE1","title":"A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-03-26","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT04199117","phase":"PHASE4","title":"Health Systems Reach Interventions Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-03-11","conditions":"Smoking, Cigarette, Smoking Cessation","enrollment":210},{"nctId":"NCT07163182","phase":"PHASE1","title":"Evaluation of Safety, Side Effects and How the Drug CHF6467 Administered Via Intranasal Route is Absorbed, Modified and Removed in Healthy Subjects","status":"RECRUITING","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2025-09-15","conditions":"Healthy Volunteers","enrollment":68},{"nctId":"NCT06670170","phase":"PHASE1","title":"A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-11-05","conditions":"Healthy Volunteers","enrollment":12},{"nctId":"NCT04478084","phase":"PHASE3","title":"Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2020-08-04","conditions":"Rabies (Healthy Volunteers)","enrollment":403},{"nctId":"NCT04368429","phase":"PHASE3","title":"Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-05-22","conditions":"Meningococcal Immunisation (Healthy Volunteers)","enrollment":360},{"nctId":"NCT03890367","phase":"PHASE3","title":"Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2019-09-12","conditions":"Meningococcal Immunisation (Healthy Volunteers)","enrollment":707},{"nctId":"NCT07171619","phase":"PHASE1","title":"Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat","status":"RECRUITING","sponsor":"SpringWorks Therapeutics, Inc.","startDate":"2025-09-09","conditions":"Healthy","enrollment":24},{"nctId":"NCT04490018","phase":"PHASE3","title":"Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2021-03-16","conditions":"Meningococcal Immunisation, Healthy Volunteers","enrollment":463},{"nctId":"NCT06284902","phase":"PHASE1","title":"Bioavailability Study of Fexofenadine HCl New Formulation Tablet","status":"COMPLETED","sponsor":"Opella Healthcare Group SAS, a Sanofi Company","startDate":"2024-02-23","conditions":"Healthy Volunteers","enrollment":25},{"nctId":"NCT06342700","phase":"PHASE1","title":"A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants","status":"COMPLETED","sponsor":"Sanofi","startDate":"2024-03-25","conditions":"Autoimmune Disorder, Healthy Volunteers","enrollment":28},{"nctId":"NCT07032558","phase":"PHASE1","title":"Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions","status":"RECRUITING","sponsor":"Haiphong University of Medicine and Pharmacy","startDate":"2025-09-20","conditions":"Healthy Volunteer","enrollment":14},{"nctId":"NCT06457204","phase":"PHASE1","title":"A Study in Healthy People to Compare Two Different Sifrol® Tablets","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-07-02","conditions":"Healthy","enrollment":28}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"Single drug references","genericName":"Single drug references","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CKD-387 is a drug being studied in a clinical trial (NCT05673369) for its pharmacokinetic profiles and safety under fasting conditions. The exact mechanism of CKD-387 is currently unknown, as indicated by ChEMBL.","enrichmentLevel":2,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}